Home  » Topic

Natco News

Shares in Natco Rally On Hepatitis Approval
Shares in Natco rallied after the company received an approval for generic Hepatitis C medicine. The stock was up over 5 per cent at Rs 1,963 on the National Stock Exchange. It also hit a new 52-week high of ...
NATCO gets a boost in favourable verdict on Copaxone
NATCO Pharma has said that the US Court of Appeals for the Federal Circuit ruling, has reversed a district court's finding related to Teva's US Patent for Copaxone. This would essentially mean that NATCO could launch the generic Copaxone - ...
Natco Gets Boost Favourable Verdict Copaxone
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X